Study | Intervention name | Estimate effect | Unit of analysis | Time point | Type of assay | Population | |
GMT (95% CI) | GMR (95% CI) | ||||||
Heterologous boost versus homologous boost | |||||||
Li 2021a |
CoronaVac/Ad5 boost | 197.40 (167.70 to 232.40) |
5.87 (4.64 to 7.43) | BAU/mL | 14 days after boost | ELISA RBD‐binding IgG | 18–59 years |
CoronaVac/CoronaVac boost | 33.60 (28.30 to 39.80) |